Pure Bioscience Financial Overview
Pure Bioscience's market cap is currently $5.18M. The company's EPS TTM is $-0.004; its P/E ratio is -2.37; Pure Bioscience is scheduled to report earnings on December 15, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
